ChemLex
Runs an automated chemical synthesis service for drugmakers: AI plans and ranks synthesis routes, and a 24/7 robotic synthesis line makes and records the compounds. It sells this as a CRO service rather than running its own pipeline.
Money and evidence
No research by this company is on the record yet.
Rounds and research, on one timeline
- 2025-12-08Undisclosed roundRound
$45M
For: hiring hardware and software engineers and chemists in Singapore, to serve a wider pipeline of pharmaceutical and materials projects
Hiring
The company's release names only Granite Asia as lead and gives no stage, no other investor and no valuation. The Star's launch report puts the company's total raised at about $80M and lists Qiming Venture Partners, LYFE Capital and Sinovation Ventures as “other notable investors in the company”, with no round, amount or date, so none is placed in a round here.
On the deal: Yinghui Kuang (Partner; spoke for the lead in the announcement, Granite Asia)
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
Other backers, round not stated
Named as backers in investor databases, reports or the investors' own posts; no source read places them in a round on the record.
Qiming Venture PartnersLYFE CapitalSinovation Ventures
Its investors also backed
Other companies on this page whose rounds name the same investor.
- Granite AsiaAureka Biotechnologies